Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Neoplasms 1Meningioma 1Leukemia, Hairy Cell 1Diabetes Mellitus 1Brain Neoplasms 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Verapamil × Clear all
NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed
113 enrolled 42 charts
Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT00706810 2017-04-13

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

University of Utah

Phase 2 Completed
8 enrolled 5 charts
CNS

Brain Neoplasms, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡